Skip to main content
. 2023 Dec 14;11:1269194. doi: 10.3389/fpubh.2023.1269194

Figure 3.

Figure 3

Adjusted vaccine effectiveness of inactivated COVID-19 vaccines by various vaccine doses against symptomatic SARS-CoV-2 infections caused by Omicron BA.2. (A) 1 dose inactivated vaccine effectiveness. (B) 2 doses inactivated vaccine effectiveness. (C) Booster dose inactivated vaccine effectiveness. *Model adjusted by gender (male and female); **Model adjusted by age groups (3–17 years, 18–64 years, and more than 65 years); ***Model adjusted by age groups and gender.